Clinical trial
Efficacy, Safety and Microbiota of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases
NCT03426683 is registered in ClinicalTrials.gov with Zhongshan Hospital Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Safety and Microbiota of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases
- Lead sponsor
- Zhongshan Hospital Xiamen University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 21, 2017
- Completion date
- December 30, 2022
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel disease(ibd)